References
- Politzer RM, Morrow JS, Leavey SB. Report on the cost-benefit/effectiveness of treatment at the Johns Hopkins Center for Pathological Gambling. J Gambling Behavior 1985; 1: 131–42
- Blume SB. Pathological gambling. In: Lowinson JH, Ruiz P, Millman RB, et al, eds. Substance abuse: a comprehensive textbook. 3rd ed. Baltimore: Williams & Wilkins, 1997: 330–7
- Shaffer HJ, Hall MN, Vanderbilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a meta-analysis. Harvard Medical School Division on Addictions, 1997
- National Gambling Impact Study Commission. Final report. Washington, DC: US Government Printing Office, 1999
- Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987; 144(9): 1184–8
- Unwin BK, Davis MK, De Leeuw JB. Pathologic gambling. Am Fam Physician 2000; 61(3): 741–9
- Ladd GT, Petry NM. Gender differences among pathological gamblers seeking treatment. Exp Clin Psychopharmacol 2002; 10(3): 302–9
- Potenza MN, Steinberg MA, McLaughlin SD, et al. Gender-related differences in the characteristics of problem gamblers using a gambling helpline. Am J Psychiatry 2001; 158(9): 1500–5
- Moreyra P, Ibanez A, Liebowitz MR, et al. Pathological gambling: addiction or obsession? Psychiatr Ann 2002; 32(3): 161–6
- Petry NM, Oncken C. Cigarette smoking is associated with increased severity of gambling problems in treatment-seeking gamblers. Addiction 2002; 97(6): 745–53
- Petry NM, Kiluk BD. Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. J Nerv Ment Dis 2002; 190(7): 462–9
- Breiter HC, Aharon I, Kahneman D, et al. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001; 30(2): 619–39
- Potenza MN, Hollander E. Pathological gambling and impulse control disorders. In: Davis KL, Coyle J, Nemeroff C, et al, eds. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002
- Potenza MN, Kosten TR, Rounsaville BJ. Pathological gambling. JAMA 2001; 286(2): 141–4
- Potenza MN, Fiellin DA, Heninger GR, et al. Gambling: an addictive behavior with health and primary care implications. J Gen Intern Med 2002; 17(9): 721–32
- Prochaska JO. Enhancing motivation to change. In: Graham AW, Schultz TK, Mayo-Smith MF, et al, eds. Principles of addiction medicine. 3rd ed. Chevy Chase, Md: American Society of Addiction Medicine, 2003: 825–37
- Grant JE, Kim SW. Pharmacotherapy of pathological gambling. Psychiatr Ann 2002; 32(3): 186–91
- Grant JE, Kim SW, Potenza MN, et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol 2003; 18(4): 243–9
- Zimmerman M, Breen RB, Posternak MA. An open-label study of Citalopram in the treatment of pathological gambling. J Clin Psychiatry 2002; 63(1): 44–8
- Sherman C. Small study marred by high attrition rate: bupropion may help pathologic gambling. Clinical Psychiatry News Dec 2001; 29(12): 17
- Crockford DN, el-Guebaly N. Naltrexone in the treatment of pathological gambling and alcohol dependence. Can J Psychiatry 1998; 43(1): 86